Literature DB >> 1411308

Spread of subclinical Chlamydia pneumoniae infection in a closed community.

B P Berdal1, O Scheel, A R Ogaard, T Hoel, T J Gutteberg, G Anestad.   

Abstract

Chlamydia pneumoniae infections may spread subclinically. The present investigation took place in a military setting. Sera drawn when the conscripts had entered their military service 2 months previously had been kept frozen and were available. In a camp with 500 people, 35 (7%) developed clinical symptoms of pneumonia. The infection was serologically verified with C. pneumoniae-specific micro-immunofluorescence technique. Of 40 healthy controls, 21 turned out to fulfil the serological criteria of infection, thus, representing subclinical cases. These 21 cases, when extrapolated to the whole camp, equalled a rate of 49% which, added to the 7% of pneumonic cases, gave a total infection rate of 56%. Pre-existing IgG antibodies were demonstrated in 10% of the pneumonic cases, 48% of the subclinical cases, and 89% of the non-infected, healthy controls. Without the access to pre-epidemic sera permitting us to establish 4-fold titre rises, the spread of subclinical C. pneumoniae infection would have been noted at 5%, and not 49% as here demonstrated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1411308     DOI: 10.3109/00365549209052628

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia.

Authors:  R Chaudhry; N Nazima; B Dhawan; S K Kabra
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

2.  Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia.

Authors:  M T Kauppinen; P Saikku; P Kujala; E Herva; H Syrjälä
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

3.  Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae.

Authors:  K Persson; J Boman
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

4.  Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.

Authors:  U V Comandini; P Maggi; P Santopadre; R Monno; G Angarano; V Vullo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

5.  Infection of Acanthamoeba castellanii by Chlamydia pneumoniae.

Authors:  A Essig; M Heinemann; U Simnacher; R Marre
Journal:  Appl Environ Microbiol       Date:  1997-04       Impact factor: 4.792

6.  Chlamydia pneumoniae and asthma.

Authors:  P J Cook; P Davies; W Tunnicliffe; J G Ayres; D Honeybourne; R Wise
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

7.  Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients.

Authors:  D H Thom; J T Grayston; L A Campbell; C C Kuo; V K Diwan; S P Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

8.  Outbreak of pneumonia in the setting of fatal pneumococcal meningitis among US Army trainees: potential role of Chlamydia pneumoniae infection.

Authors:  Fatimah S Dawood; John F Ambrose; Bruce P Russell; Anthony W Hawksworth; Jonas M Winchell; Nina Glass; Kathleen Thurman; Michele A Soltis; Erin McDonough; Agnes K Warner; Emily Weston; Nakia S Clemmons; Jennifer Rosen; Stephanie L Mitchell; Dennis J Faix; Patrick J Blair; Matthew R Moore; John Lowery
Journal:  BMC Infect Dis       Date:  2011-06-02       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.